MEGAN DEHART: Open Payments
NPI 1366778938 · MONTGOMERY, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$413 in 20 payments from 14 companies in 2025. Trend: 2023 $524 · 2024 $507 · 2025 $413
Food & beverage: $413
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $94 |
| Novo Nordisk Inc | 3 | $48 |
| Lilly USA, LLC | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Sage Therapeutics, LLC | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $23 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $23 |
| Almatica Pharma LLC | 1 | $22 |
| Exact Sciences Corporation | 1 | $17 |
Products named: Veozah, Wegovy, ZEPBOUND, CAPLYTA, ZURZUVAE, MYFEMBREE, XIFAXAN, LOREEV XR.
Industry payments across OH — which companies pay providers there.
